Ampio Pharmaceuticals Inc (AMPE):企業の財務・戦略的SWOT分析

◆英語タイトル:Ampio Pharmaceuticals Inc (AMPE) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH230074FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ampio Pharmaceuticals Inc (Ampio) formerly Chay Enterprises Inc, operates as a bio pharmaceutical company that discovers and develops novel therapeutic candidates for inflammatory conditions. The company develops compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level. It provides products for the treatment of osteoarthritis, diabetic macular edema, and other prevalent, inflammatory diseases. Ampio’s products include low molecular weight fraction of human serum albumin and ultra-low dose of danazol. Its ultra-low dose of danazol is used for the oral treatment of diabetic macular edema. The company conducts research on various future indications for optina. It partners with other bio pharmaceutical companies for its research activities. Ampio is headquartered in Englewood, Colorado, the US.

Ampio Pharmaceuticals Inc Key Recent Developments

Apr 07,2021: Valneva’s Covid-19 vaccine shows robust immune response in trial
Mar 19,2021: Ampio Pharmaceuticals to Present at Benzinga Biotech Small Cap Conference
Mar 10,2021: Ampio Pharmaceuticals to Participate in the 33rd Annual Virtual ROTH Conference on March 15-17, 2021
Mar 03,2021: Ampio pharmaceuticals reports fourth quarter 2020 financial results and provides business update
Feb 16,2021: Ampio Pharmaceuticals, Inc. to Present at Upcoming Investor Conference

This comprehensive SWOT profile of Ampio Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Ampio Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Ampio Pharmaceuticals Inc – Key Information
Ampio Pharmaceuticals Inc – Overview
Ampio Pharmaceuticals Inc – Key Employees
Ampio Pharmaceuticals Inc – Key Employee Biographies
Ampio Pharmaceuticals Inc – Key Operational Heads
Ampio Pharmaceuticals Inc – Major Products and Services
Ampio Pharmaceuticals Inc – History
Ampio Pharmaceuticals Inc – Company Statement
Ampio Pharmaceuticals Inc – Locations And Subsidiaries
Ampio Pharmaceuticals Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Ampio Pharmaceuticals Inc – Business Description
Ampio Pharmaceuticals Inc – Corporate Strategy
Ampio Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Ampio Pharmaceuticals Inc – Strengths
Ampio Pharmaceuticals Inc – Weaknesses
Ampio Pharmaceuticals Inc – Opportunities
Ampio Pharmaceuticals Inc – Threats
Ampio Pharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Ampio Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Ampio Pharmaceuticals Inc, Key Information
Ampio Pharmaceuticals Inc, Key Ratios
Ampio Pharmaceuticals Inc, Share Data
Ampio Pharmaceuticals Inc, Major Products and Services
Ampio Pharmaceuticals Inc, History
Ampio Pharmaceuticals Inc, Key Employees
Ampio Pharmaceuticals Inc, Key Employee Biographies
Ampio Pharmaceuticals Inc, Key Operational Heads
Ampio Pharmaceuticals Inc, Other Locations
Ampio Pharmaceuticals Inc, Subsidiaries
Ampio Pharmaceuticals Inc, Key Competitors
Ampio Pharmaceuticals Inc, SWOT Analysis
Ampio Pharmaceuticals Inc, Ratios based on current share price
Ampio Pharmaceuticals Inc, Annual Ratios
Ampio Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Ampio Pharmaceuticals Inc (AMPE):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Berry Global Group Inc:企業の戦略・SWOT・財務分析
    Berry Global Group Inc - Strategy, SWOT and Corporate Finance Report Summary Berry Global Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • CellSeed Inc (7776):企業の製品パイプライン分析
    Summary CellSeed Inc (CellSeed) is a developer of regenerative medicine. The company’s products include epithelial cell sheet for corneal regeneration, regenerated cardiac patch, epithelial cell sheet for esophageal regeneration, cell sheet for periodontal tissue regeneration and regenerated cartila …
  • 3M Co (MMM):医療機器:M&Aディール及び事業提携情報
    Summary 3M Company (3M) is a diversified technology company that specializes in the development, manufacture and marketing of a wide range of innovative products. The company develops technology platforms, including adhesives, abrasives, light management, microreplication, non woven materials, nanot …
  • Australian Vintage Limited:企業の戦略・SWOT・財務情報
    Australian Vintage Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Vintage Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Landis+Gyr AG (LAND):企業の財務・戦略的SWOT分析
    Landis+Gyr AG (LAND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Pepticom Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Pepticom Ltd (Pepticom) is a drug discovery and development company focused on novel peptide drug candidates. The company's artificial intelligence platform for peptide design models based on the target's solved crystal structure of the target protein. Its products includes copaxone, used fo …
  • The Seibels Bruce Group, Inc:企業の戦略・SWOT・財務情報
    The Seibels Bruce Group, Inc - Strategy, SWOT and Corporate Finance Report Summary The Seibels Bruce Group, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Lensar Inc-医療機器分野:企業M&A・提携分析
    Summary Lensar Inc (Lensar), a subsidiary of Alphaeon Corp is a medical device company that designs, develops and manufactures laser and advanced 3D imaging technology and devices for refractive cataract surgery. The company provides surgeon with superior femtosecond laser technology. It offers vari …
  • Bionik Laboratories Corp (BNKL):企業の製品パイプライン分析2018
    Summary Bionik Laboratories Corp (Bionik) is a medical device company that designs and develops transformational technologies, prosthetics and assisted robotic products and solutions. The company provides rehabilitation technology that senses patient movements and limitations. It provides lower body …
  • Ocean Power Technologies Inc (OPTT):電力:M&Aディール及び事業提携情報
    Summary Ocean Power Technologies, Inc. (OPT) is a provider of ocean energy solutions. The company harnesses the abundant wave power to draw out renewable energy; and commercializes ocean wave power conversion technology products. The company's PB3 PowerBuoy integrates patented technologies in hydrod …
  • LIC of India:企業の戦略・SWOT・財務分析
    LIC of India - Strategy, SWOT and Corporate Finance Report Summary LIC of India - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Peabody Energy Corporation:企業のM&A・事業提携・投資動向
    Peabody Energy Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Peabody Energy Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Helius Medical Technologies Inc (HSM):製品パイプライン分析
    Summary Helius Medical Technologies Inc (HMT) is a medical device company that offers neurological wellness solutions. The company offers development, licensing and acquisition of non-invasive platform technologies for amplifying the brain’s ability to heal itself. It offers development of technolog …
  • First Electric Cooperative Corporation:企業の発電所・SWOT分析2018
    First Electric Cooperative Corporation - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informati …
  • Albireo Pharma Inc (ALBO):医療機器:M&Aディール及び事業提携情報
    Summary Albireo Pharma Inc (Albireo), formerly Biodel Inc., focuses on the development and commercialization of innovative bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal (GI) disorders and diseases where inappropriate flow of bile causes severe med …
  • Lea County Electric Cooperative Inc:企業の戦略的SWOT分析
    Lea County Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Qenos Pty Ltd:企業の戦略的SWOT分析
    Qenos Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • First Republic Bank:企業の戦略・SWOT・財務分析
    First Republic Bank - Strategy, SWOT and Corporate Finance Report Summary First Republic Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Multi Corporation:企業の戦略・SWOT・財務情報
    Multi Corporation - Strategy, SWOT and Corporate Finance Report Summary Multi Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • SMART Global Holdings, Inc. (SGH):企業の財務・戦略的SWOT分析
    SMART Global Holdings, Inc. (SGH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆